We have shown that nitric oxide (NO) regulates c-fos gene expression via cGMP-dependent protein kinase (Gkinase), but NO's precise mechanism of action is unclear. We now demonstrate that: (1) NO targets two transcriptional elements in the fos promoter, i.e., the fos AP-1 binding site and the cAMP-response element (CRE); (2) NO activation of these two enhancer elements requires the CRE binding protein CREB because a dominant negative CREB fully inhibits NO transactivation of reporter genes whereas dominant negative Fos or CCAAT enhancer binding proteins have no eect; (3) CREB is phosphorylated by G-kinase in vitro and its phosphorylation increases in vivo when Gkinase is activated either directly by cGMP or indirectly by NO via soluble guanylate cyclase; (4) NO activation of fos promoter elements requires nuclear translocation of G-kinase but not activation of mitogen-activated protein kinases. Oncogene (2000) 19, 6324 ± 6333.
Introduction
The c-fos proto-oncogene is an immediate-early gene which is transcriptionally activated by a wide array of stimuli including growth factors, cytokines, cellular stress, and neuronal activity (Wisdom, 1999; Wang and Prywes, 2000; Karin, 1995) . As an essential component of the AP-1 transcription factor complex, c-Fos is required for growth factor-induced proliferation and normal cell cycle progression, and c-Fos functions as an eector of neoplastic transformation and is involved in cell dierentiation and apoptosis (Wisdom, 1999) . Study of the c-fos promoter has greatly enhanced our knowledge about nuclear targets of many dierent signaling pathways including those involving Janus kinases, mitogen-activated protein kinases (MAP kinases), calcium/calmodulin-dependent protein kinases (Cam-kinases), and cyclic nucleotide-dependent protein kinases (Wisdom, 1999; Karin, 1995) .
Nitric oxide (NO) is a unique biological messenger involved in regulating cell growth, dierentiation and apoptosis and many of NO's eects are mediated via changes in gene expression (Schmidt et al., 1993; Eigenthaler et al., 1998; Chiche et al., 1998) . NO increases c-fos mRNA expression in many dierent cell types, including neuronal cells, epithelial cells and ®broblasts (Peunova and Enikolopov, 1993; Haby et al., 1994; Morris, 1995; Qiang et al., 1999; Bosco-Felley et al., 1994; Pilz et al., 1995) . In neuronal cells, NOinduced increases in c-fos expression may contribute to long-term changes in synaptic plasticity which are thought to be critical for learning and memory (Peunova and Enikolopov, 1993; Lev-Ram et al., 1997; Qiang et al., 1999; Lu et al., 1999) .
Through thiol nitrosylation, NO can directly modulate the activities of transcription factors such as NFkB and c-Jun, or activate Ras and the MAP kinase pathway leading to transcriptional changes (Matthews et al., 1996; Klatt et al., 1999; Lander et al., 1997; Gonzalez-Zulueta et al., 2000) . However, many of NO's eects are mediated via activation of soluble guanylate cyclase with a consequent increase in the intracellular cGMP concentration (Schmidt et al., 1993; Eigenthaler et al., 1998) . We showed that NO regulation of the fos promoter requires guanylate cyclase and cGMP-dependent protein kinase (Gkinase), thus de®ning an NO/cGMP/G-kinase signal transduction pathway in NO regulation of c-fos gene expression (Idriss et al., 1999; Gudi et al., 1999) . We found that G-kinase I can translocate to the nucleus via an active transport system when baby hamster kidney (BHK) cells are treated with membrane-permeable cGMP analogs (Gudi et al., 1997) and recently Wang et al. made similar observations in B35 neuronal cells ; in addition, other workers have shown G-kinase I present in the nucleus of human mononuclear leukocytes, alveolar macrophages, and activated neutrophils (Pryzwansky et al., 1995; Wyatt et al., 1991) . We identi®ed a nuclear localization sequence (NLS) in G-kinase I, and by using speci®c mutations in the NLS which prevented the enzyme's translocation to the nucleus, we demonstrated that nuclear translocation of G-kinase I in response to cGMP was required for cGMP-mediated transcriptional activation of the fos promoter (Gudi et al., 1997) . However, these results have been questioned recently by investigators who were unable to demonstrate nuclear translocation of G-kinase I; these authors concluded that G-kinase regulates gene expression via as yet unde®ned, extranuclear mechanisms (Collins and Uhler, 1999) . Moreover, recent reports indicate that NO can activate the mitogenactivated protein kinases p38 and p42/p44 (Erk-1/2) in a cGMP-and G-kinase-dependent fashion in various cell types, and it has been suggested that p38 and/or p42/p44 activation could mediate activation of the fos promoter by NO (Komalavilas et al., 1999; Browning et al., 2000; Callsen et al., 1998; Parenti et al., 1998) .
In this manuscript we show that NO targets the CRE and the fos AP-1 (FAP) site in the fos promoter, both of which can bind CREB. In addition, we show that NO induces nuclear translocation of G-kinase I and phosphorylation of CREB in a guanylate cyclase-and G-kinase-dependent manner. NO's activation of the fos promoter required CREB and nuclear G-kinase, but did not require activation of MAP kinases.
Results
NO activates the CRE and FAP enhancer elements of the fos promoter NO induction of c-fos mRNA and NO-mediated transactivation of the fos promoter appear to be cGMP-mediated, because the eects are inhibited by speci®c guanylate cyclase inhibitors and mimicked by cGMP analogs (Pilz et al., 1995; Haby et al., 1994; Peunova and Enikolopov, 1993; Idriss et al., 1999) . In BHK cells, which have very low endogenous guanylate cyclase and G-kinase activity, we demonstrated that transactivation of the fos promoter by the NOreleasing agent DETA-NONOate is strictly dependent on co-transfection of guanylate cyclase and G-kinase expression vectors and increased intracellular cGMP levels (Idriss et al., 1999) .
When we transfected BHK cells with guanylate cyclase, G-kinase and various fos promoter deletion mutants, reporter gene induction by DETA-NONOate was similar to induction by 8-Br-cGMP [ (Idriss et al., 1999) and data not shown]. NO induction of the fos promoter required the presence of the CRE which in addition to the fos AP-1 (FAP) binding site were the only single enhancer elements in the fos promoter that conferred strong NO responsiveness to a minimal promoter: DETA-NONOate increased luciferase and CAT activity approximately 4 ± 6-fold in BHK cells transfected with the reporters pCRE-Luc (containing multiple CREs) or pTF5/53-CAT (containing a single copy of the FAP site) along with guanylate cyclase and G-kinase I expression vectors (Figure 1a ,b, open bars). Of note, the amount of G-kinase expression vector transfected into BHK cells was adjusted to produce Gkinase activity comparable to the activity found in vascular smooth muscle cells and platelets (Gudi et al., 1996; Idriss et al., 1999) . The small increase in reporter gene activities in untreated cells transfected with the guanylate cyclase and G-kinase expression vectors compared to cells transfected with empty vector has been noted before and is likely from basal NO production by BHK cells (Idriss et al., 1999) . Both reporter genes are highly responsive to A-kinase activation by 8-Br-cAMP (Figure 1 , open bars, shown for cells transfected with empty vector); however, DETA-NONOate had no signi®cant eect on cells expressing guanylate cyclase without G-kinase ( Figure  7 ) indicating that there was no signi®cant crossactivation of A-kinase by cGMP under the experimental conditions. We have previously shown that the eect of cGMP on the fos promoter is independent of A-kinase (Gudi et al., 1996) .
A-CREB prevents NO activation of fos promoter elements CREB is required for transcriptional activation of the fos promoter in response to many dierent stimuli and CREB may be one of the primary targets through which NO regulates c-fos expression (Ahn et al., 1998; Peunova and Enikolopov, 1993) . Both the CRE and the FAP enhancer elements can bind CREB and the related transcription factor ATF-1 in vitro (Wang and . After 24 h in low serum-containing media, cells were treated with 1 mM 8-Br-cAMP, 1 mM 8-Br-cGMP or 250 mM DETA-NONOate for 8 h as indicated. In a, luciferase activity was normalized to b-galactosidase activity and in b, CAT activity was normalized to luciferase activity; the normalized activity of untreated cells transfected with empty vector was assigned a value of 1. Transfection of A-CREB by itself had no eect on pTF5/53-CAT expression but it did increase pCRE-Luc expression approximately twofold; this may be because unphosphorylated CREB or CREM-related proteins with repressor functions are removed from the CRE (Shaywitz and Greenberg, 1999) . A-Fos and A-C/EBP expression did not in¯uence reporter gene activities in untreated cells. The data are expressed as fold activation over untreated cells transfected with empty vector in the absence or presence of the respective dominant negative inhibitor and are the mean+s.d. of three independent experiments performed in duplicate Prywes, 2000; Berkowitz et al., 1989) . However, the CRE element can also bind AP-1 complexes and the FAP element may bind AP-1 and the transcription factor C/EBP-b in addition to CREB/ATF-1 (SassoneCorsi et al., 1990; Metz and Zi, 1992) .
To examine the contribution of dierent transcription factors to the NO-induced transcriptional activation of the CRE-and FAP-containing reporter genes, we used a series of dominant negative proteins which were constructed by fusing an acidic amphipathic extension onto the N-terminus of the CREB-, Fosand C/EBP-speci®c leucine zipper domain (Ahn et al., 1998; Olive et al., 1997) . These proteins, termed A-CREB, A-Fos and A-C/EBP, function as speci®c inhibitors of each transcription factor family because they form stable high-anity heterodimers with the endogenous family members and thereby prevent their DNA binding (Ahn et al., 1998; Olive et al., 1997) . For example, A-CREB selectively inhibits the DNA binding of CREB, ATF-1 and CREM without in¯uencing the DNA binding of Fos-, Jun-, and C/ EBP-related proteins even at a 10-fold molar excess (Ahn et al., 1998) .
A-CREB almost completely inhibited cAMP-induced activation of the pCRE-Luc and pTF5/53-CAT constructs in BHK cells (Figure 1a 
NO induces CREB phosphorylation
CREB phosphorylation on serine 133 is necessary for CREB interaction with the co-activators CREB binding protein (CBP) and p300 and these interactions are required for CREB-mediated transcriptional activation (Arias et al., 1994; Shaywitz and Greenberg, 1999) . A number of dierent protein kinases have been shown to phosphorylate CREB on serine 133 in vitro and in vivo, including A-kinase, Cam-kinases and the growth factor-induced protein kinases RSK 1 ± 3, MAPKAP-K 2/3, and MSK-1 whose activities are regulated by p38 and p42/p44 MAP kinases (Shaywitz and Greenberg, 1999) .
Using an antibody speci®c for serine 133-phosphorylated CREB, we found that DETA-NONOate and the related NO-releasing agent PAPA-NONOate induced a high degree of CREB phosphorylation in guanylate cyclase-and G-kinase-expressing cells ( The two NO-releasing drugs also induced phosphorylation of ATF-1, which is recognized by the antiphospho-CREB antibody and is the faster migrating band observed [ (Ginty et al., 1993) and product information, New England Biolabs]. CREB and ATF-1 also showed increased phosphorylation in Gkinase-expressing cells treated with 8-Br-cGMP ( Figure  2a , compare lanes 1 and 2), but the eect of 8-Br- Incubation with 250 mM DETANONOate (lane 4) was for 4 h; cells in lanes 1, 3 and 6 were left untreated. Western blots were generated as described in Materials and methods using an anti-phospho-CREB (Ser133) antibody (upper panel); the faster migrating band is likely phosphorylated ATF-1 which the antibody also recognizes. The blots were reprobed with an anti-CREB antibody (lower panel) showing equal amounts of the protein present in each lane. (b) BHK cells were transfected with empty vector (EV, upper panels) or with expression vectors for guanylate cyclase and EE epitope-tagged G-kinase I (GC/GK, lower panels) and 32 h later were treated for 1 h with 1 mM 8-Br-cAMP (upper right panel) or for 4 h with 250 mM DETA-NONOate (lower right panels). Cells in upper panels were stained with an anti-phospho-CREB (Ser133) antibody and cells in lower panels were stained simultaneously with both the anti-phospho-CREB antibody and an anti-EE epitope antibody (to demonstrate G-kinase) cGMP was signi®cantly less than that of 8-Br-cAMP ( Figure 2a , compare lanes 2 and 8). There was a similar amount of CREB present in all samples as evidenced by reprobing the blot with an anti-CREB antibody ( Figure 2a , lower panel). CREB phosphorylation induced by PAPA-NONOate was ®rst detectable at 15 min and was maximal by 1 ± 2 h; kinetics were slower in DETA-NONOate-treated cells, consistent with the fact that NO release from this drug is slower (data not shown).
We also assessed CREB phosphorylation by immuno¯uorescence ( Figure 2b ). In cells transfected with empty vector, 8-Br-cAMP increased the amount of phosphorylated CREB in the nuclei (upper panel of Figure 2b ), and in cells transfected with guanylate cyclase and EE epitope-tagged G-kinase I vectors, DETA-NONOate increased phospho-CREB staining only in the nuclei of successfully transfected cells (in the lower panels, cells were doubly stained with the anti-phospho-CREB antibody and an anti-EE epitope antibody to demonstrate G-kinase expression). Of note, the EE epitope-tagged G-kinase co-localized with phospho-CREB in the nucleus, as will be discussed below. CREB phosphorylation was detectable in 495% of successfully transfected cells demonstrating nuclear G-kinase.
NO does not activate p38 or p42/p44 MAP kinases in BHK or CS-54 cells
In several cell types, NO activates the p38 and/or p42/ p44 MAP kinases which can translocate to the nucleus and activate CREB kinases of the RSK, MAPKAP-K and MSK families (Komalavilas et al., 1999; Browning et al., 2000; Callsen et al., 1998; Parenti et al., 1998; Shaywitz and Greenberg, 1999) . Thus, the eect of NO on CREB phosphorylation could be mediated by activation of the p38 and/or p42/p44 MAP kinase pathways. We examined the eect of NO on p38 and p42/p44 MAP kinase activities in G-kinase-and guanylate cyclase-expressing BHK cells using antibodies speci®c for the phosphorylated, activated forms of p38 and p42/p44. Treating cells with PAPANONOate for up to 4 h did not signi®cantly induce p38 or p42/p44 phosphorylation, whereas treating cells with lipopolysaccharide (LPS) or epidermal growth factor (EGF) strongly induced p38 or p42/p44 phosphorylation, respectively (Figure 3a shows 15 min and 30 min timepoints for p38, Figure 3b shows 5 min and 15 min timepoints for p42/p44; similar results were obtained with DETA-NONOate, not shown). We also performed experiments in which we co-transfected BHK cells with G-kinase and guanylate cyclase and an HA epitope-tagged p44. We measured p44 kinase activity directly in anti-HA immunoprecipitates using myelin basic protein as the substrate and found that PAPA-NONOate slightly inhibited p44 activity while EGF increased p44 activity 410-fold ( (Suhasini et al., 1998) and data not shown). We then examined the eect of NO on the activity of ATF-2 and ELK-1, two transcription factors which are direct nuclear targets of activated p38 and p42/p44, respectively. Treating guanylate cyclase-and G-kinase-expressing BHK cells with DETA-NONOate or PAPA-NONOate did not increase the transcriptional activity of Gal4-ATF-2 or Gal4-Elk-1 constructs, but both constructs were eciently activated by serum (data not shown).
Since rapid induction of p42/p44 MAP kinase phosphorylation by cGMP analogs has been described in G-kinase-expressing rat aortic smooth muscle cells (Komalavilas et al., 1999) , we examined the eect of NO on p42/p44 phosphorylation in rat pulmonary arterial smooth muscle cells (CS-54 cells) which maintain dierentiated properties through multiple passages and contain endogenous soluble guanylate cyclase and G-kinase I activity (Rothman et al., 1992; Idriss et al., 1999) . Treating CS-54 cells with PAPANONOate for up to 4 h had no signi®cant eect on p42/p44 phosphorylation under conditions where serum-stimulation resulted in signi®cant activation of p42/p44 MAP kinases ( Figure 3c shows 5 and 15 min timepoints). Similar results were obtained in CS-54 cells pre-treated with L-NAME to inhibit endogenous NO production; L-NAME treatment had no eect on basal p42/p44 phosphorylation levels (data not shown). It appears that the activation of p42/p44 MAP kinases by NO/cGMP is a cell type-speci®c phenomenon.
Next, we examined the eect of pharmacological inhibition of the p38 or p42/p44 MAP kinase pathways on NO induction of CREB-dependent reporter gene expression. BHK cells were transfected with G-kinase, guanylate cyclase and pCRE-Luc and cultured in the presence or absence of SB203580 (p38 inhibitor) or 6) . Cells in lanes 1 and 4 were left untreated. Western blots were generated using phospho-p38-speci®c antibodies (Pp38); duplicate blots were probed with p38-speci®c antibodies for loading controls (p38). (b) BHK cells were transfected and cultured as described above and treated with 10 ng/ml of EGF (lanes 2 and 3) or 250 mM PAPA-NONOate (lanes 5 and 6) for 5 min (lanes 2 and 5) or 15 min (lanes 3 and 6). Cells in lanes 1 and 4 were left untreated. Duplicate Western blots were probed with phospho-p42/p44-speci®c antibodies (P-ERK) or with p42/ p44-speci®c antibodies (ERK). (c) CS-54 cells were cultured for 36 h in low serum-containing medium and treated with 250 mM PAPA-NONOate (lanes 2 and 3) or 10% fetal bovine serum (lanes 5 and 6) for either 5 min (lanes 2 and 5) or 15 min (lanes 3 and 6). Cells in lanes 1 and 4 were left untreated. Western blots were probed as described in (b) U0126 (inhibitor of MEK-1/2, the kinases responsible for p42/p44 activation) prior to stimulation with PAPA-NONOate. NO activation of reporter gene expression was not reduced when cells were pre-treated with 10 mM SB203580 or 10 mM U0126 (Figure 4a shows data for the pCRE-Luc reporter; similar results were obtained with pTF5/53-CAT). To our surprise, we found that pre-treating cells with a dierent MEK-1/2 inhibitor, PD98059, inhibited NO induction of the reporter genes by 40 ± 50%; PD98059 inhibited cAMP induction of pCRE-Luc to a similar degree (data not shown). Similar results have been reported by Seternes et al. (1999) , who found that PD98059 inhibited cAMP-induced Gal4-CREB activation by about 60% without aecting CREB phosphorylation in NIH3T3 cells; cAMP does not activate p42/p44 MAP kinases in these cells. Since control experiments showed that U0126 inhibited serum-induced p42/p44 phosphorylation more eectively than PD98059 (data not shown and Favata et al., 1998) , we conclude that the eect of PD98059 is unrelated to MEK-1/2 inhibition.
We also examined the eect of p38 and MEK-1/2 inhibitors on NO-induced reporter gene expression in CS-54 cells. Treatment with PAPA-NONOate induced luciferase expression from pCRE-Luc approximately sixfold in these cells and this eect was not reduced in the presence of 10 mM SB203580 or 10 mM U0126 (Figure 4b) .
We conclude that NO-induced activation of CREBdependent reporter genes in BHK and CS-54 cells does not require activation of p38 or p42/p44 MAP kinases.
G-kinase phosphorylates CREB in vitro
There is controversy in the literature whether Gkinase directly phosphorylates CREB in vitro: one group demonstrated G-kinase phosphorylation of D-CREB (a splice variant of CREB) puri®ed from bacteria, while another group was unable to demonstrate G-kinase phosphorylation of CREB immunoprecipitated from olfactory neurons (Colbran et al., 1992; Moon et al., 1999) . We, therefore, transfected BHK cells with expression vectors encoding either glutathione-S-transferase (GST) or GST-tagged CREB; we isolated GST and GST-CREB on glutathione agarose beads and incubated the beads with puri®ed G-kinase or A-kinase and [g-
32
PO 4 ]ATP. In control experiments, the activities of G-kinase and A-kinase were determined with the synthetic peptide Kemptide and equal amounts of G-kinase and Akinase activity were used for the incubation. G-kinase phosphorylated GST-CREB, albeit less eciently than A-kinase, but GST was not phosphorylated by either kinase (Figure 5a ). GST-CREB puri®ed from bacteria was similarly phosphorylated by G-kinase, whereas GST-CREB containing a serine 133 to alanine mutation was not (Figure 5b ). These results demonstrate that G-kinase can directly phosphorylate CREB on serine 133.
NO induces nuclear translocation of G-kinase I
We and others have shown nuclear translocation of Gkinase I in cGMP-treated cells (Gudi et al., 1997; , whereas Collins and Uhler (1999) were unable to demonstrate nuclear staining of Gkinase. Since CREB is localized in the nucleus and NO induces CREB phosphorylation, we examined whether NO induces nuclear translocation of G-kinase I. We treated BHK cells and CS-54 rat pulmonary arterial smooth muscle cells for up to 4 h with 250 mM DETANONOate or PAPA-NONOate prior to immunostaining for G-kinase I; the BHK cells had been transfected previously with guanylate cyclase and G-kinase I expression vectors and the CS-54 cells were pre-treated with the NO synthase inhibitor L-NAME to lower endogenous NO production. We found that the NO donors induced nuclear translocation of G-kinase I in Figure 4 Eect of SB203580 and U0126 on NO-induced reporter gene expression. (a) BHK cells were transfected with pCRE-Luc, pRSV-bGal and guanylate cyclase and G-kinase expression vectors as described in the legend of Figure 1 ; 24 h later some cultures were treated with 10 mM SB203580 or 10 mM U0126 for 1 h before adding 250 mM PAPA-NONOate for 8 h. (b) CS-54 cells were transfected with pCRE-Luc and pRSV-bGal as described in Materials and methods; cells were treated with the inhibitors and PAPA-NONOate as described in (a). Treating CS-54 cells with 1 mM 8-Br-cAMP increased luciferase expression from pCRE-Luc 16+2-fold (data not shown). Reporter gene activities were normalized as described in the legend of Figure 1 with the activity of untreated cells assigned a value of 1; the data represent the mean+s.d. of three independent experiments performed in duplicate NO regulation of the fos promoter T Gudi et al both cell types: results for DETA-NONOate in BHK cells are shown in Figure 6a , upper set of panels, and CS-54 cells are shown in Figure 6b . Nuclear translocation was detected as early as 15 ± 30 min after addition of PAPA-NONOate (data not shown); at 1 h, nuclear G-kinase was detectable in 73% of the NO-treated cell population compared to only in 14% of the untreated cells (200 G-kinase-expressing cells were scored; cells were scored as positive for nuclear G-kinase if they demonstrated brighter nuclear than cytoplasmic Gkinase immuno¯uorescence). The NO donors did not induce nuclear translocation of G-kinase I expressed in BHK cells in the absence of co-expression of guanylate cyclase. The NLS we previously identi®ed in G-kinase I is between amino acids 404 and 411 and we showed that mutating lysine 407 to an acidic residue, i.e., to glutamic acid, prevented the enzyme's translocation to the nucleus in response to cGMP analogs while mutating it to a neutral residue, i.e., to alanine, was without eect (Gudi et al., 1997) . When we transfected guanylate cyclase and G-kinase (K 407 ?E) into BHK cells, DETA-NONOate no longer induced G-kinase translocation to the nucleus but when we transfected G-kinase (K 407 ?A) into the cells, DETA-NONOate induced nuclear translocation of the enzyme ( Figure  6a , middle and lower panels). We also demonstrated that G-kinase with a lysine to glutamic acid mutation outside the NLS, i.e., (K 399 ?E), still translocated to the nucleus on DETA-NONOate treatment.
In the experiments described above, we tested three dierent rabbit polyclonal anti-G-kinase antibodies; all three antibodies detected the enzyme as a single band on Western blots of transfected BHK cells and none of the antibodies produced¯uorescence signals in mocktransfected cells (data not shown). Two of the three antibodies (including one purchased from StressGen) detected NO-or cGMP-activated G-kinase I in the nucleus while the third one did not; presumably, this latter antibody was directed against a G-kinase epitope that is masked in the nucleus and these results may explain why Collins and Uhler did not observe nuclear G-kinase I in their studies (Collins and Uhler, 1999). As described above in Figure 2b , an anti-EE antibody showed that EE epitope-tagged G-kinase I co-localized with phosphorylated CREB in the nucleus in DETANONOate-treated BHK cells. 
Transactivation of reporter genes by NO requires nuclear translocation of G-kinase
To determine whether the nuclear translocation of Gkinase I induced by NO in BHK cells is required for the transcriptional eects of NO, we transfected cells with pCRE-Luc or pTF5/53-CAT along with guanylate cyclase and either wild type or the three mutant Gkinase I expression vectors described above. In cells transfected with the extranuclear G-kinase mutant (K 407 ?E), DETA-NONOate caused a minimal nonsigni®cant (P50.2, Student's t-test) increase in reporter gene activities while in cells transfected with the control G-kinase mutants (K 407 ?A) and (K 399 ?E), it induced the reporters to the same extent as with wild type Gkinase I (Figure 7a,b) . The dierence in transactivating potentials of the G-kinase constructs was not secondary to dierent expression levels as approximately equal amounts of each protein were expressed ( Figure  7c) . Moreover, the speci®c activities of the G-kinase constructs in vitro and their phosphorylation of the extranuclear substrate VASP in vivo are indistinguishable from wild type G-kinase I (Gudi et al., 1997 . Thus, regulation of reporter genes by NO appears to require nuclear translocation of G-kinase I.
Discussion
In this study we de®ned a pathway by which NO regulates c-fos expression: NO activates guanylate cyclase and G-kinase, induces G-kinase nuclear translocation and CREB phosphorylation, and CREB mediates activation of the fos promoter via the CRE and FAP site, possibly in conjunction with other CREB-related proteins. In BHK and CS-54 cells, we found that NO does not activate p38 and p42/p44, thus excluding indirect activation of CREB kinases via Gkinase-dependent or -independent activation of these MAP kinases. Since G-kinase directly phosphorylates CREB in vitro and nuclear translocation of the enzyme is required for NO activation of fos promoter elements, it is likely that G-kinase mediates the CREB phosphorylation observed in the nucleus of NO-treated cells. Kinetic studies have demonstrated that G-kinase phosphorylates a synthetic peptide corresponding to the phosphorylation site in CREB with a fourfold lower V max compared to A-kinase but the K m was similar for both kinases (Colbran et al., 1992) . For comparison, Cam-kinase IV phosphorylates CREB in vitro with a 410-fold lower V max than A-kinase ), yet it is generally accepted that nuclear Cam-kinase IV mediates CREB phosphorylation in vivo (Matthews et al., 1994; Sun et al., 1994; Finkbeiner et al., 1997) .
We observed that the kinetics of CREB phosphorylation in NO-(or 8-Br-cGMP)-treated cells were comparable to the kinetics of G-kinase nuclear translocation; CREB phosphorylation and G-kinase nuclear staining were detectable at 15 ± 30 min and maximal at 1 ± 2 h after the addition of PAPANONOate. For comparison, CREB phosphorylation was observed within 5 ± 10 min after the addition of 8-Br-cAMP (T Gudi, unpublished results) and nuclear translocation of the catalytic subunit of A-kinase is typically detectable within 5 ± 10 min after cAMP (Hagiwara et al., 1993; Meinkoth et al., 1990) . Although Western blots obtained with phosphospeci®c antibodies are only semi-quantitative, the degree of CREB phosphorylation in NO-(or 8-BrcGMP)-stimulated cells was at least threefold less than that observed in 8-Br-cAMP-treated cells and NOinduced transcriptional activation of the fos promoter elements was about threefold less than that induced by cAMP. In some cell types, greater dierences between NO/cGMP-and cAMP-induced activation of CREcontaining promoters are observed, suggesting that some cell type-speci®c factors may be involved (Collins and Uhler, 1999; Velcich and Zi, 1990) . In many instances, CREB phosphorylation does not correlate well with transcriptional activation and it is clear that CREB phosphorylation is necessary but not sucient for transcriptional activation (Shaywitz and Greenberg, 1999; Seternes et al., 1999) . We have previously shown that the transactivation potential of Gal4-CREB is stimulated by cGMP in a G-kinase-dependent manner (Gudi et al., 1996) . Peunova and Enikolopov (1993) observed that NO acted synergistically with calcium to enhance transcriptional activation by a chimeric Gal4-CREB construct; these authors did not observe any eect of NO by itself which may be due to the fact that most PC12 cells have very low endogenous G-kinase activity .
We found that NO did not activate p38 or p42/p44 MAP kinases in BHK or CS-54 cells and that the p38 inhibitor SB203580 and the MEK-1/2 inhibitor U0126 had no eect on activation of fos promoter elements by NO. These data indicate that the eects of NO and cGMP on the fos promoter are independent of MAP kinase activation in BHK and CS-54 cells; however, they do not exclude the possibility that p38 or p42/p44 MAP kinase activation by NO/cGMP may contribute to NO/cGMP regulation of the fos promoter in other cell types. For example, in neuronal cells, p42/p44 is activated by NO/cGMP as well as by cAMP and calcium, and it has been demonstrated that p42/p44 activation contributes to increased CREB phosphorylation and CRE-dependent transcription in response to cAMP and calcium (Gonzalez-Zulueta et al., 2000; Roberson et al., 1999; Impey et al., 1998) .
Interestingly, AP-1-and C/EBP-related proteins do not appear to play a major role in the NO/cGMP-or cAMP-mediated induction of the fos promoter. This is surprising, since NO and cAMP increase AP-1 DNA binding activity and AP-1 binds to the FAP site in vitro (Pilz et al., 1995; Haby et al., 1994; Angel and Karin, 1991; Fisch et al., 1989; Berkowitz et al., 1989) . However, the FAP site diers from a canonical AP-1 binding site and AP-1 binding may not enhance transcription (Velcich and Zi, 1990; Gauthier-RouvieÁ ere et al., 1992) . Although cAMP-induced C/EBP-b phosphorylation results in nuclear translocation of the protein and induction of the fos promoter in PC-12 cells (Metz and Zi, 1991) , we found that BHK cells express very low levels of C/EBP-related proteins (T Gudi and RB Pilz, unpublished results).
The physiological signi®cance of our ®ndings is clear in neuronal cells, in which NO has been demonstrated to increase c-fos mRNA expression and to be critically involved in long-term regulation of synaptic plasticity (Qiang et al., 1999; Morris, 1995; Peunova and Enikolopov, 1993; Haby et al., 1994; Lu et al., 1999; Lev-Ram et al., 1997; Zhuo et al., 1994) . Our data de®ne one mechanism whereby NO induces gene expression and suggest that G-kinase should be added to the growing list of CREB kinases, even though its kinetics of CREB phosphorylation dier from that of A-kinase. This mechanism of NO-induced transcriptional regulation is in contrast to direct NO-mediated S-nitrosylation of transcription factors like NF-kB and c-Jun (Matthews et al., 1996; Klatt et al., 1999) .
Materials and methods
Cell culture and transfection BHK cells were transfected using Lipofectamine TM (Gibco-BRL) as described previously (Gudi et al., 1996; Suhasini et al., 1998) with either 50 ng of pTF5/53-CAT, which contains the chloramphenicol acetyltransferase (CAT) gene under control of the FAP site [nucleotides 7303 to 7281 of the human c-fos promoter (Fisch et al., 1989) ], or 50 ng of pCRE-Luc, which contains the luciferase gene under control of ®ve tandemly-arranged CREs (Stratagene). As internal controls for transfection eciency, cells were transfected with either 50 ng of the luciferase expression vector pRSV-Luc or 50 ng of the b-galactosidase expression vector pRSV-bGal. Where indicated, cells received 100 ng of expression vectors encoding the a 1 and b 1 subunits of rat soluble guanylate cyclase (Nakane et al., 1990) and 300 ng of a human GKinase Ib expression vector (Gudi et al., 1996) . The three mutant forms of G-kinase I containing single amino acid substitutions in or near the NLS were described previously (Gudi et al., 1997) . In experiments with dominant negative forms of CREB, Fos, and C/EBP, cells were transfected with 50 ng of expression vectors encoding A-CREB, A-Fos or A-C/EBP (Ahn et al., 1998; Olive et al., 1997) . In all transfection experiments, corresponding amounts of the empty expression vectors were used to keep the total amount of DNA constant (the CMV-based vectors pCB6 and pRC/ CMV were used for expression of G-kinases and dominant negative transcription factors, respectively). Cells were kept in low serum-containing media and harvested 36 h post transfection as described previously (Gudi et al., 1996) . Where indicated, 1 mM 8-Br-cGMP (Biolog Life Sciences), 250 mM DETA-NONOate (ethanamine-2,2'-(hydroxynitrosohydrazone)bis-, Cayman Chemical) or 250 mM PAPA-NONOate ((Z)-1-[N-(3aminopropyl)-N-(n-propyl)amino]diazen-1-ium-1,2-diolate, Cayman Chemical) were added 8 h prior to harvest as indicated. The BHK cells used in these studies demonstrated less basal NO production than those described previously (Idriss et al., 1999) . The p38 inhibitor SB203580 and the MEK-1/2 inhibitors U0126 and PD98059 were from Calbiochem and were added 1 h prior to the addition of NO donors where indicated.
CS-54 rat pulmonary arterial smooth muscle cells were provided by A Rothman, UCSD, and were routinely cultured in Dulbecco's Modi®ed Eagle Medium (DME) supplemented with 10% fetal bovine serum (FBS). In some experiments, NO synthase activity was inhibited in these cells using 1 mM L-NAME (N G -nitro-L-arginine-methyl ester, Alexis Corp.). CS-54 cells were transfected with FuGENE 6 TM (Boehringer) 3 ml per 0.6 mg of DNA in serum-free OptiMEM medium, they were allowed to recover for 2 h in 10% FBS and were then transferred to DME supplemented with 0.1% FBS and 0.1% bovine serum albumin; 250 mM PAPA-NONOate was added during the last 8 h prior to harvesting and treatment with SB203580 or U0126 was as described above for BHK cells.
Reporter gene assays
CAT activity, luciferase activity, and b-galactosidase activity were measured as described previously using [ 14 C]chloram-phenicol/butyryl-coenzyme A, luciferin/ATP, and the chemiluminescent substrate Galacton TM , respectively (Pilz et al., 1995; Gudi et al., 1996) .
Assessment of CREB phosphorylation
BHK cells transfected with soluble guanylate cyclase and GKinase Ib expression vectors were harvested directly in SDS polyacrylamide gel electrophoresis sample buer and samples were subjected to Western immunoblotting using a rabbit polyclonal anti-phospho-CREB (Ser133) antibody (New England Biolab, 1 : 500 dilution) according to the manufacturer's protocol.
For in vitro phosphorylation experiments, GST, GST-CREB or GST-CREB(Ser 133 -Ala) were isolated from transfected BHK cells or from bacteria using glutathione agarose. The agarose beads were washed in 10 mM Tris-HCl pH 7.5, 10 mM MgCl 2 , 1 mM dithiothreitol, and 10 mM b-glycerolphosphate and incubated in the same buer with 10 mM [g-
32
PO 4 ]ATP (0.4 Ci/mol) for 10 min at 308C in the presence of puri®ed G-kinase with 10 mM 8-Br-cGMP or puri®ed catalytic subunit of A-kinase as described (Suhasini et al., 1998) .
Assessment of MAP kinase activation
BHK cells were transfected and treated with the indicated drugs for 5, 15, 30 min, 1, 2 or 4 h, and harvested as described above. CS-54 cells were grown to about 50% con¯uency and transferred to media containing 0.1% FBS and 0.1% bovine serum albumin for 36 h prior to treatment with the indicated drugs. Western blots were generated using antibodies speci®c for activated, Tyr 182 -phosphorylated p38 (New England Biolab, 1 : 1000 dilution) or activated, phosphorylated p42/p44 as previously described (Suhasini et al., 1998) . Equal loading of protein was veri®ed on duplicate Western blots probed with antibodies speci®c for p38 or p42/ p44 (New England Biolab, 1 : 1000 dilution).
In experiments in which BHK cells were co-transfected with G-kinase, guanylate cyclase and HA epitope-tagged p44, MAP kinase activity was measured in anti-HA immunoprecipitates using myelin basic protein and [g-
32
PO 4 ]ATP as described (Suhasini et al., 1998) . In some experiments, BHK cells were transfected with expression vectors encoding Gal4-Elk-1 or Gal4-ATF-1, G-kinase, guanylate cyclase, the reporter gene pGAL4-LUC (containing four Gal4 DNA binding sites) and the control vector pRSV-bGal; cells were stimulated with 250 mM DETA-NONOate or 20% serum for 4 ± 8 h prior to harvesting.
Immunofluorescent staining of G-kinase I and Phospho-CREB Cells were ®xed as described previously (Gudi et al., 1997) . After blocking with 5% bovine serum albumin for 1 h, cells were incubated with rabbit polyclonal antibodies against Gkinase Ib [StressGen Biotechnologies (KAP-PK005) and Markert et al., (1995) , both antibodies were used at 1 : 500 dilution] followed by¯uorescein-5-isothio-cyanate-conjugated (FITC) goat anti-rabbit immunoglobulin G (IgG). For double immunostaining, EE epitope-tagged G-kinase I was transfected into cells and 36 h later cells were ®xed and stained simultaneously with a mouse monoclonal anti-EE epitope antibody [ (Grussenmeyer et al., 1985) , at 1 : 1000] and the rabbit polyclonal anti-phospho-CREB (Ser133) antibody described above, followed by a rhodamine-conjugated goat anti-mouse IgG and an FITC-conjugated goat anti-rabbit IgG. Cells were visualized with a Zeiss¯uorescence microscope using appropriate ®lters.
